Subgroup and per-protocol analysis of the randomized European trial on isolated systolic hypertension in the elderly

Archives of Internal Medicine

Volumn 158, Issue 15, 1998, Pages 1681-1691

  Staessen, J A ^a   Fagard, R ^a   Thijs, L ^a   Cells, H ^a   Birkenhager, W H ^a   Bulpitt, C J ^a   De Leeuw, P W ^a   Fletcher, A E ^a   Babarskiene, M R ^a   Forette, F ^a   Kocemba, J ^a   Laks, T ^a   Leonetti, G ^a   Nachev, C ^a   Petrie, J C ^a   Tuomilehto, J ^a   Vanhanen, H ^a   Webster, J ^a   Yodfat, Y ^a   Zanchetti, A ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPYRIDINE DERIVATIVE; ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE; NITRENDIPINE;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR DISORDERS; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; NITRENDIPINE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 0032563661     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.15.1681     Document Type: Article

References (41)